US30205M2008 - Common Stock
EXICURE INC
NASDAQ:XCUR (11/18/2024, 5:03:07 PM)
After market: 3.98 +0.04 (+1.02%)3.94
+1.04 (+35.86%)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The company is headquartered in Chicago, Illinois and currently employs 6 full-time employees. The company went IPO on 2018-05-09. The firm is into exploring strategic alternatives to maximize stockholder value. The company is engaging in a broader exploration of strategic alternatives. This effort involves exploring growth through transactions with potential partners that see opportunity in joining an existing, publicly traded organization. The firm is exploring transactions in industries unrelated to its historical operations. The company does not generate any revenues. The company wholly owned subsidiary is Exicure Operating Company that holds all material assets and conducts all business activities and operations of the Company.
EXICURE INC
2430 N. Halsted St.
Chicago ILLINOIS 60614
P: 18476731700
CEO: David A. Giljohann
Employees: 5
Website: https://www.exicuretx.com/
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Top movers in Monday's pre-market session
Here you can normally see the latest stock twits on XCUR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: